EE318 Reduction of Costs Associated With the Use of Emicizumab in Prophylaxis in Pediatric Patients Diagnosed With Severe Hemophilia A and Inhibitors in El Salvador
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.617
https://www.valueinhealthjournal.com/article/S1098-3015(24)00732-0/fulltext
Title :
EE318 Reduction of Costs Associated With the Use of Emicizumab in Prophylaxis in Pediatric Patients Diagnosed With Severe Hemophilia A and Inhibitors in El Salvador
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00732-0&doi=10.1016/j.jval.2024.03.617
First page :
Section Title :
Open access? :
No
Section Order :
10092